Launch week offerEnds in00h00m00s

annual Promonthly Pro

Małgorzata Pieniążek

Wroclaw Medical University

Poland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Poland Professors in Cell Biology Cell Biology professors in Poland

Articles (7)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Collaborators (7)

Tomasz Trombik

Medical University of Lublin

POLAND

View details

Piotr Donizy

Professor, Head of the Division of General and Experimental Pathology

Wroclaw Medical University

POLAND

View details

Antonina Mazur

Assistant Professor

Wroclaw University of Science and Technology

POLAND

View details

Aleksander Czogalla

Associate Professor / Head of the Department

University of Wrocław

POLAND

View details

Zuzana Bielcikova

Charles University

CZECH REPUBLIC

View details

Renata Pacholczak-Madej

National Cancer Institute

POLAND

View details

Aleksandra Konieczna

Assistant Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Małgorzata Pieniążek

Research Interests

Make your next move.

Explore related searches

Articles (7)

Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe

Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study

Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland

Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis

Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort

Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer

ABCA1 transporter promotes the motility of human melanoma cells by modulating their plasma membrane organization

Collaborators (7)

Tomasz Trombik

Piotr Donizy

Antonina Mazur

Aleksander Czogalla

Zuzana Bielcikova

Renata Pacholczak-Madej

Aleksandra Konieczna

Make your next move.